Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapy

Douglas B. Johnson, Erika K. Wallender, Daniel N. Cohen, Sunaina S. Likhari, Jeffrey P. Zwerner, Jennifer G. Powers, Lisa Shinn, Mark C. Kelley, Richard W. Joseph, Jeffrey A. Sosman

Research output: Contribution to journalArticlepeer-review

70 Scopus citations

Fingerprint Dive into the research topics of 'Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences